| Effect of patiromer on hyperkalemia recurrence in older chronic kidney disease patients taking RAAS inhibitors MR Weir, DA Bushinsky, WW Benton, SD Woods, MR Mayo, SP Arthur, ... The American Journal of Medicine 131 (5), 555-564. e3, 2018 | 44 | 2018 |
| Real-world management of hyperkalemia with patiromer among United States Veterans CP Kovesdy, EO Gosmanova, SD Woods, JJ Fogli, CG Rowan, ... Postgraduate Medicine 132 (2), 176-183, 2020 | 24 | 2020 |
| Managing hyperkalemia in high-risk patients in long-term care. R Kumar, L Kanev, SD Woods, M Brenner, B Smith The American journal of managed care 23 (2 Suppl), S27-S36, 2017 | 22 | 2017 |
| The economic implications of hyperkalemia in a Medicaid managed care population NR Desai, P Reed, PJ Alvarez, J Fogli, SD Woods, MK Owens American Health & Drug Benefits 12 (7), 352, 2019 | 20 | 2019 |
| Multiple comorbid conditions and healthcare resource utilization among adult patients with hyperkalemia: a retrospective observational cohort study using association rule mining D Dai, A Sharma, PJ Alvarez, SD Woods Journal of Multimorbidity and Comorbidity 12, 26335565221098832, 2022 | 11 | 2022 |
| A predictive model for progression of chronic kidney disease to kidney failure using a large administrative claims database D Dai, PJ Alvarez, SD Woods ClinicoEconomics and Outcomes Research, 475-486, 2021 | 9 | 2021 |
| Healthcare resource utilization and costs associated with hyperkalemia in a large managed care population A Sharma, PJ Alvarez, SD Woods, J Fogli, D Dai Journal of Pharmaceutical Health Services Research 12 (1), 35-41, 2021 | 9 | 2021 |
| A model to predict risk of Hyperkalemia in patients with chronic kidney disease using a large administrative claims database A Sharma, PJ Alvarez, SD Woods, D Dai ClinicoEconomics and Outcomes Research, 657-667, 2020 | 8 | 2020 |
| Hyperkalemia management in older adults with diabetic kidney disease receiving renin-angiotensin-aldosterone system inhibitors: a post hoc analysis of the AMETHYST-DN clinical … GL Bakris, SD Woods, PJ Alvarez, SP Arthur, R Kumar Kidney Medicine 3 (3), 360-367. e1, 2021 | 5 | 2021 |
| Healthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patients NR Desai, PJ Alvarez, L Golestaneh, SD Woods, SG Coca, CG Rowan Journal of Medical Economics 24 (1), 1025-1036, 2021 | 5 | 2021 |
| Real-world evaluation of patiromer utilization and its effects on serum potassium in veterans with end stage kidney disease D Pinnell, S Patel, J Qualls, W Chen, A Rathod, SD Woods, S Boutin, ... Medicine 101 (50), e32367, 2022 | 3 | 2022 |
| Assessing patiromer utilization and associated serum potassium changes in US veterans with prior sodium polystyrene sulfonate exposure S Patel, D Pinnell, J Qualls, A Rathod, W Chen, S Boutin, SD Woods, ... Medicine 102 (9), e33134, 2023 | 1 | 2023 |
| IMPROVEMENT IN ITCH-RELATED SLEEP DISRUPTION WITH DIFELIKEFALIN IN PATIENTS WITH MODERATE TO SEVERE CHRONIC KIDNEY DISEASE ASSOCIATED PRURITUS UNDERGOING HEMODIALYSIS: A POST … D Weiner, J Budden, S Woods, S Krishnarajah, I Morin, F Menzaghi, ... American Journal of Kidney Diseases 79 (4), S124-S124, 2022 | 1 | 2022 |
| CKD-ASSOCIATED PRURITUS AFTER 12 WEEKS OF THERAPY WITH DIFELIKEFALIN AMONG HEMODIALYSIS PATIENTS WITH SEVERE PRURITUS: A POST-HOC ANALYSIS OF PHASE 3 STUDIES D Weiner, J Budden, S Woods, S Krishnarajah, I Morin, F Menzaghi, ... AMERICAN JOURNAL OF KIDNEY DISEASES 79 (4), S124-S124, 2022 | 1 | 2022 |
| Hospital and emergency department utilization in US veterans with hyperkalemia CP Kovesdy, E Gosmanova, SD Woods, JJ Fogli, CG Rowan, JL Hansen, ... Diabetes 69 (Supplement 1), 1087, 2020 | 1 | 2020 |
| Emergency department visits and hospitalizations in US veterans with hyperkalemia CP Kovesdy, EO Gosmanova, SD Woods, JJ Fogli, CG Rowan, ... AMERICAN JOURNAL OF KIDNEY DISEASES 73 (5), 690-690, 2019 | 1 | 2019 |
| Disparities in real-world utilization patterns of potassium binders in US veterans with hyperkalemia EO Gosmanova, CP Kovesdy, SD Woods, J Fogli, CG Rowan, JL Hansen, ... PAT 210 (1.9), 1, 2019 | 1 | 2019 |
| PUK3 MULTIPLE CHRONIC CONDITIONS AMONG ADULT PATIENTS WITH HYPERKALEMIA: A RETROSPECTIVE COHORT STUDY USING ASSOCIATION RULE MINING D Dai, A Sharma, P Alvarez, SD Woods, JJ Fogli, J Fernandes Value in Health 23, S377, 2020 | | 2020 |
| 1118-P: Effect of Patiromer in Patients 75 Years or Older with Diabetic Kidney Disease and Hyperkalemia Receiving a RAAS Inhibitor GL Bakris, SD Woods, PJ Alvarez, J Fogli, S Arthur, MR Mayo, R Kumar Diabetes 68 (Supplement_1), 2019 | | 2019 |
| PUK23 A MODEL TO PREDICT RISK OF HYPERKALEMIA IN CKD PATIENTS USING A LARGE ADMINISTRATIVE CLAIMS DATABASE A Sharma, P Alvarez, SD Woods, J Fogli, D Dai, RR Mehta Value in Health 22, S385, 2019 | | 2019 |
Christopher G. Rowan PhDPharmacoepidemiologist, COHRDATA, INCVerified email at cohrdata.com
